Suppr超能文献

CAR和PXR参与草药成分对CYP2B6基因表达的转录调控。

Involvement of CAR and PXR in the transcriptional regulation of CYP2B6 gene expression by ingredients from herbal medicines.

作者信息

Xu Cong, Luo Mengyue, Jiang Huidi, Yu Lushan, Zeng Su

机构信息

a Laboratory of Pharmaceutical Analysis and Drug Metabolism, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research , College of Pharmaceutical Sciences, Zhejiang University , Hangzhou , P.R. China and.

出版信息

Xenobiotica. 2015;45(9):773-81. doi: 10.3109/00498254.2015.1020076. Epub 2015 Jun 12.

Abstract

1. Induction of hepatic drug-metabolizing enzymes can affect drug efficacy and cause toxicity. However, so far, limited information is available regarding the molecular mechanism how herbal medicines induce human CYP2B6, which metabolizes many of the clinically used therapeutics and activates several pro-carcinogens or toxicants. Accumulated evidence suggests that the human constitutive androstane receptor (hCAR) and the human pregnane X receptor (hPXR) play important roles in trans-activation of CYP2B6. In this study, we investigated the effects of 68 Chinese herbal ingredients on the receptor specificity of hPXR/hCAR-mediated CYP2B6 induction by luciferase reporter gene assays in transiently transfected HepG2 cells and on the expression of CYP2B6 in LS174T cells. 2. The HepG2 cells were transiently transfected with human CYP2B6 luciferase promoter reporter plasmids along with hPXR or hCAR3. The results indicated that apigenin (Api), curcumol (Cur) and praeruptorin A (Pra A) were identified as potent activators of hPXR, and Pra A was also a ligand of hCAR. 3. Furthermore, CYP2B6 mRNA expression in LS174T cells treated with the three herbal ingredients was determined by real-time polymerase chain reaction. By combining western blot and LC-MS/MS, CYP2B6 protein expression and catalytic activity induced by the three herbal ingredients were measured. 4. Our observation showed Api and Cur up-regulated CYP2B6 expression by transactivation of hPXR, and Pra A acted as the ligand of both hPXR and hCAR to induce CYP2B6 expression.

摘要
  1. 肝脏药物代谢酶的诱导可影响药物疗效并导致毒性。然而,迄今为止,关于草药如何诱导人CYP2B6的分子机制的信息有限,CYP2B6可代谢许多临床使用的治疗药物并激活多种前致癌物或毒物。越来越多的证据表明,人组成型雄甾烷受体(hCAR)和人孕烷X受体(hPXR)在CYP2B6的反式激活中起重要作用。在本研究中,我们通过瞬时转染的HepG2细胞中的荧光素酶报告基因测定,研究了68种中草药成分对hPXR/hCAR介导的CYP2B6诱导的受体特异性的影响,以及对LS174T细胞中CYP2B6表达的影响。2. 将人CYP2B6荧光素酶启动子报告质粒与hPXR或hCAR一起瞬时转染HepG2细胞。3. 结果表明,芹菜素(Api)、莪术醇(Cur)和前胡素A(Pra A)被鉴定为hPXR的有效激活剂,并且Pra A也是hCAR的配体。4. 此外,通过实时聚合酶链反应测定用这三种草药成分处理的LS174T细胞中CYP2B6 mRNA的表达。通过结合蛋白质免疫印迹和液相色谱-串联质谱法,测定了这三种草药成分诱导的CYP2B6蛋白表达和催化活性。5. 我们的观察结果表明,Api和Cur通过hPXR的反式激活上调CYP2B6表达,并且Pra A作为hPXR和hCAR的配体诱导CYP2B6表达。 (注:原文中无序号5,这里为使译文逻辑更完整添加)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验